Pharma news
Americas
Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients. 7 August 2017
Americas
Novartis has been hit with a patent infringement lawsuit by Plexxikon, a drug-discovery company. 7 August 2017
Pharma
UK-based biopharmaceutical company Shire is assessing the potential to spin off its neuroscience franchise. 4 August 2017
Americas
Drugs maker Endo Pharmaceuticals has accused Lupin Atlantis, a subsidiary of Lupin, of patent infringement. 2 August 2017
Asia-Pacific
China has launched an IP rights protection centre aimed at providing protection for the biopharmaceutical and high-end manufacturing industries. 2 August 2017
Americas
Sheppard, Mullin, Richter & Hampton has hired Kandace Watson, a lawyer with experience representing companies in complex transactions in IP-intensive industries. 2 August 2017
Asia-Pacific
Takeda has entered into an exclusive licensing agreement with biopharmaceutical company Tesaro to develop a novel cancer therapy in Japan. 1 August 2017
Americas
AstraZeneca has entered into an oncology collaboration with Merck, under which the companies will co-develop AstraZeneca’s Lynparza. 31 July 2017
Pharma
A European Patent Office Board of Appeal has published its decision that invalidated a patent owned by Bristol-Myers Squibb (BMS) which covered a blockbuster anti-cancer drug. 27 July 2017
Americas
GSK has revealed plans to cut back on research and development (R&D), while Eli Lilly announced a plan to focus its R&D resources on oncology. 27 July 2017